These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31916644)

  • 21. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
    Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
    J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complexity of screening PMS2 in DNA isolated from formalin-fixed paraffin-embedded material.
    Jansen AML; Tops CMJ; Ruano D; van Eijk R; Wijnen JT; Ten Broeke S; Nielsen M; Hes FJ; van Wezel T; Morreau H
    Eur J Hum Genet; 2020 Mar; 28(3):333-338. PubMed ID: 31616036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-read nanopore sequencing enables accurate confirmation of a recurrent PMS2 insertion-deletion variant located in a region of complex genomic architecture.
    Watson CM; Crinnion LA; Simmonds J; Camm N; Adlard J; Bonthron DT
    Cancer Genet; 2021 Aug; 256-257():122-126. PubMed ID: 34116445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of heterozygous
    Wang Q; Leclerc J; Bougeard G; Olschwang S; Vasseur S; Cassinari K; Boidin D; Lefol C; Naïbo P; Frébourg T; Buisine MP; Baert-Desurmont S;
    J Med Genet; 2020 Jul; 57(7):487-499. PubMed ID: 31992580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and structural characterization of two variants of uncertain significance in the PMS2 gene.
    D'Arcy BM; Blount J; Prakash A
    Hum Mutat; 2019 Apr; 40(4):458-471. PubMed ID: 30653781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
    Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of
    Okkels H; Lagerstedt-Robinsson K; Wikman FP; Hansen TVO; Lolas I; Lindberg LJ; Krarup HB
    Genet Test Mol Biomarkers; 2019 Sep; 23(9):688-695. PubMed ID: 31433215
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.
    De Vos M; Hayward BE; Picton S; Sheridan E; Bonthron DT
    Am J Hum Genet; 2004 May; 74(5):954-64. PubMed ID: 15077197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in a pseudogene highly homologous to PMS2.
    Chadwick RB; Meek JE; Prior TW; Peltomaki P; de La Chapelle A
    Hum Mutat; 2000 Dec; 16(6):530. PubMed ID: 11102987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dealing with Pseudogenes in Molecular Diagnostics in the Next Generation Sequencing Era.
    Claes KBM; Rosseel T; De Leeneer K
    Methods Mol Biol; 2021; 2324():363-381. PubMed ID: 34165726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
    Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
    Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).
    Ramchander NC; Ryan NA; Crosbie EJ; Evans DG
    BMC Med Genet; 2017 Apr; 18(1):40. PubMed ID: 28381238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene.
    Vaughn CP; Baker CL; Samowitz WS; Swensen JJ
    Genes Chromosomes Cancer; 2013 Jan; 52(1):107-12. PubMed ID: 23012243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.
    Soares BL; Brant AC; Gomes R; Pastor T; Schneider NB; Ribeiro-Dos-Santos Â; de Assumpção PP; Achatz MIW; Ashton-Prolla P; Moreira MAM
    Fam Cancer; 2018 Jul; 17(3):387-394. PubMed ID: 28932927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.
    Brea-Fernández AJ; Cameselle-Teijeiro JM; Alenda C; Fernández-Rozadilla C; Cubiella J; Clofent J; Reñé JM; Anido U; Milá M; Balaguer F; Castells A; Castellvi-Bel S; Jover R; Carracedo A; Ruiz-Ponte C
    Clin Genet; 2014 Jun; 85(6):583-8. PubMed ID: 23837913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PMS2 germline mutation c.943C>T (p.Arg315*)-induced Lynch syndrome-associated ovarian cancer.
    Guo X; Wu W; Gao H; Li X; He Q; Zhu Y; Liu N
    Mol Genet Genomic Med; 2019 Jun; 7(6):e721. PubMed ID: 31056861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan.
    Sugano K; Nakajima T; Sekine S; Taniguchi H; Saito S; Takahashi M; Ushiama M; Sakamoto H; Yoshida T
    Cancer Sci; 2016 Nov; 107(11):1677-1686. PubMed ID: 27589204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics.
    Morak M; Steinke-Lange V; Massdorf T; Benet-Pages A; Locher M; Laner A; Kayser K; Aretz S; Holinski-Feder E
    Fam Cancer; 2020 Apr; 19(2):161-167. PubMed ID: 32002723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.